Literature DB >> 15295061

Long-term leptin-replacement therapy for lipoatrophic diabetes.

Ken Ebihara, Hiroaki Masuzaki, Kazuwa Nakao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15295061     DOI： 10.1056/NEJM200408053510623

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.

Authors:  Cristina Adelia Meehan; Elaine Cochran; Andrea Kassai; Rebecca J Brown; Phillip Gorden
Journal:  Expert Rev Clin Pharmacol       Date:  2015-10-14       Impact factor: 5.045

Review 2.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

Review 3.  Narrative review: the role of leptin in human physiology: emerging clinical applications.

Authors:  Theodore Kelesidis; Iosif Kelesidis; Sharon Chou; Christos S Mantzoros
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

Review 4.  Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases.

Authors:  Kazuwa Nakao; Akihiro Yasoda; Ken Ebihara; Kiminori Hosoda; Masashi Mukoyama
Journal:  J Mol Med (Berl)       Date:  2009-10       Impact factor: 4.599

5.  Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration.

Authors:  Hyun-Seuk Moon; Joo Young Huh; Fadime Dincer; Benjamin E Schneider; Per-Olof Hasselgren; Christos S Mantzoros
Journal:  Diabetes       Date:  2014-09-23       Impact factor: 9.461

6.  Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet.

Authors:  T Kusakabe; H Tanioka; K Ebihara; M Hirata; L Miyamoto; F Miyanaga; H Hige; D Aotani; T Fujisawa; H Masuzaki; K Hosoda; K Nakao
Journal:  Diabetologia       Date:  2009-01-24       Impact factor: 10.122

7.  Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.

Authors:  Marissa Lightbourne; Anna Wolska; Brent S Abel; Kristina I Rother; Mary Walter; Yevgeniya Kushchayeva; Sungyoung Auh; Robert D Shamburek; Alan T Remaley; Ranganath Muniyappa; Rebecca J Brown
Journal:  J Endocr Soc       Date:  2020-12-04

Review 8.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871

9.  The role of leptin in the control of insulin-glucose axis.

Authors:  Marie Amitani; Akihiro Asakawa; Haruka Amitani; Akio Inui
Journal:  Front Neurosci       Date:  2013-04-08       Impact factor: 4.677

10.  Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle.

Authors:  Chitoku Toda; Tetsuya Shiuchi; Haruaki Kageyama; Shiki Okamoto; Eulalia A Coutinho; Tatsuya Sato; Yuko Okamatsu-Ogura; Shigefumi Yokota; Kazuyo Takagi; Lijun Tang; Kumiko Saito; Seiji Shioda; Yasuhiko Minokoshi
Journal:  Diabetes       Date:  2013-03-25       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.